Why the study?
Hypofibrinolysis is a recognized risk factor for recurrent cardiovascular events in patients with STEMI, but its mechanistic determinants are not well understood.
In STEMI patients, endogenous fibrinolysis is influenced by fibrinogen, hs-CRP, and shear-induced platelet reactivity, highlighting crosstalk between coagulation and inflammation.
Answers are grounded in this paper and cite their sources.
Does not support practice change in STEMI; leaves open prospective validation of fibrinogen, hs-CRP, and platelet reactivity as fibrinolysis modulators.
Hypofibrinolysis is a recently-recognized risk factor for recurrent cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI), but the mechanistic determinants of this are not well understood. In patients with STEMI, we show that the effectiveness of endogenous fibrinolysis in whole blood is determined in part by fibrinogen level, high sensitivity C-reactive protein, and shear-induced platelet reactivity, the latter directly related to the speed of thrombin generation. Our findings strengthen the evidence for the role of cellular components and bidirectional crosstalk between coagulatory and inflammatory pathways as determinants of hypofibrinolysis.
No takes yet. Share an insight, caveat, or question.
Kanji et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: